只有在排除所有其他可能病因后，才能认定新型冠状病毒2型疫苗接种是血栓性血小板减少性紫癜的病因。
SARS-CoV-2 Vaccination Can Only Be Held Responsible for Thrombotic Thrombocytopenic Purpura After All Differentials Have Been Ruled Out.
作者信息
Finsterer Josef
机构信息
Neurology and Neurophysiology Center, Vienna, Austria.
出版信息
HCA Healthc J Med. 2024 Dec 1;5(6):639-640. doi: 10.36518/2689-0216.1677. eCollection 2024.
Abstract
Description This letter to the editor addresses limitations to holding COVID vaccines responsible for the diagnosis of thrombotic thrombocytopenic purpura and discusses the potential differential diagnoses that must be considered.
摘要
描述 这封致编辑的信阐述了将新冠疫苗认定为血栓性血小板减少性紫癜诊断原因的局限性，并讨论了必须考虑的潜在鉴别诊断。
相似文献
1
SARS-CoV-2 Vaccination Can Only Be Held Responsible for Thrombotic Thrombocytopenic Purpura After All Differentials Have Been Ruled Out.只有在排除所有其他可能病因后，才能认定新型冠状病毒2型疫苗接种是血栓性血小板减少性紫癜的病因。
HCA Healthc J Med. 2024 Dec 1;5(6):639-640. doi: 10.36518/2689-0216.1677. eCollection 2024.
2
First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.首例接种 SARS-CoV-2 疫苗后发生的血栓性血小板减少性紫癜 - 病例报告。
BMC Nephrol. 2021 Dec 11;22(1):411. doi: 10.1186/s12882-021-02616-3.
3
Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine.获得性血栓性血小板减少性紫癜：一种与 BNT162b2 疫苗相关的罕见疾病。
J Thromb Haemost. 2021 Sep;19(9):2314-2317. doi: 10.1111/jth.15420. Epub 2021 Jul 7.
4
Acute Thrombotic Thrombocytopenic Purpura: Rare and Life-Threatening Side Effect of Recent BNT-162b2 COVID-19 Vaccination.急性血栓性血小板减少性紫癜：近期BNT-162b2新冠疫苗接种罕见且危及生命的副作用
HCA Healthc J Med. 2022 Dec 30;3(6):343-348. doi: 10.36518/2689-0216.1384. eCollection 2022.
5
Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.COVID-19 疫苗接种和/或同时 COVID-19 感染可能引发免疫性血栓性血小板减少性紫癜（iTTP）复发。
BMJ Case Rep. 2022 Jul 28;15(7):e247524. doi: 10.1136/bcr-2021-247524.
6
SARS-CoV-2 vaccination and immune thrombotic thrombocytopenic purpura.严重急性呼吸综合征冠状病毒2型疫苗接种与免疫性血栓性血小板减少性紫癜
Blood. 2022 Apr 21;139(16):2570-2573. doi: 10.1182/blood.2022015545.
7
Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.接种 COVID-19 疫苗后的血栓性血小板减少性紫癜（TTP）：已报告病例的系统评价。
Thromb Res. 2022 Jun;214:115-121. doi: 10.1016/j.thromres.2022.04.020. Epub 2022 May 2.
8
Hemostatic Profile and Serological Response of Patients with Immune Thrombotic Thrombocytopenic Purpura after Receiving BNT162b2 Vaccine: A Prospective Study.免疫性血栓性血小板减少性紫癜患者接受 BNT162b2 疫苗后的止血谱和血清学反应：一项前瞻性研究。
Thromb Haemost. 2023 Oct;123(10):945-954. doi: 10.1055/s-0043-1768921. Epub 2023 May 12.
9
COVID-19 vaccine (mRNA BNT162b2) and COVID-19 infection-induced thrombotic thrombocytopenic purpura in adolescents.新型冠状病毒肺炎疫苗（信使核糖核酸BNT162b2）与青少年新型冠状病毒肺炎感染诱发的血栓性血小板减少性紫癜
Pediatr Blood Cancer. 2022 Jun;69(6):e29681. doi: 10.1002/pbc.29681. Epub 2022 Apr 4.
10
Case Report: Rabies Vaccine-Induced Thrombotic Thrombocytopenic Purpura in a Patient With Systemic Lupus Erythematosus.病例报告：红斑狼疮患者接种狂犬病疫苗后引发血栓性血小板减少性紫癜。
Front Immunol. 2022 Apr 25;13:851316. doi: 10.3389/fimmu.2022.851316. eCollection 2022.
本文引用的文献
1
Acute Thrombotic Thrombocytopenic Purpura: Rare and Life-Threatening Side Effect of Recent BNT-162b2 COVID-19 Vaccination.急性血栓性血小板减少性紫癜：近期BNT-162b2新冠疫苗接种罕见且危及生命的副作用
HCA Healthc J Med. 2022 Dec 30;3(6):343-348. doi: 10.36518/2689-0216.1384. eCollection 2022.
2
Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report.BNT162b2 mRNA新冠疫苗加强针接种后引发的疫苗诱导免疫性血栓性血小板减少症：一例报告
Vaccines (Basel). 2023 Jun 19;11(6):1115. doi: 10.3390/vaccines11061115.
3
A case report: Hemophagocytic lymphohistiocytosis and thrombotic thrombocytopenic purpura in an otherwise healthy woman.病例报告：一名健康女性发生噬血细胞性淋巴组织细胞增生症和血栓性血小板减少性紫癜。
Medicine (Baltimore). 2023 May 19;102(20):e33803. doi: 10.1097/MD.0000000000033803.
4
In vitro characterization of a novel Arg102 mutation in the ADAMTS13 metalloprotease domain.在 ADAMTS13 金属蛋白酶结构域中新型 Arg102 突变的体外特征分析。
J Thromb Haemost. 2023 Mar;21(3):682-690. doi: 10.1016/j.jtha.2022.12.003. Epub 2022 Dec 22.
5
Suspected Metformin-induced Cobalamin Deficiency Mimicking Thrombotic Thrombocytopenic Purpura.疑似二甲双胍诱发的钴胺素缺乏症，酷似血栓性血小板减少性紫癜。
Cureus. 2020 Feb 8;12(2):e6921. doi: 10.7759/cureus.6921.
6
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜。
Blood. 2017 May 25;129(21):2836-2846. doi: 10.1182/blood-2016-10-709857. Epub 2017 Apr 17.
Zotero 插件